This page shows the latest Adderall XR news and features for those working in and with pharma, biotech and healthcare.
The neuroscience arm includes Shire’s attention-deficit hyperactivity drugs such as Adderall XR (mixed amphetamine salts) and brought in $2.66bn in sales last year.
modest $288m by 2020, mainly because of anticipated payer resistance in the US as the new drug has the same ingredients as Adderall XR. ... Either way the new drug is a boost to Shire's ADHD franchise now that Adderall XR and Intuniv (guanfacine) have
Adults already receive treatment for ADHD off-label using drugs such as Adderall and Adderall XR - both also based on mixed amphetamine salts - but it is though that a sizeable proportion
Shire reaches $56.5m US marketing malpractice settlement. Justice Department agreement covers activities for drugs including Adderall. ... The allegations included its attention deficit disorder (ADHD) drugs Adderall XR and Vyvanse.
Pay-for-delay deals lead to inflated drug prices says study. Based on analysis of delayed market entry of generic Adderall XR in US. ... The study models a deal that delayed generic competition to Shire's attention-deficit hyperactivity disorder (ADHD)
Despite these setbacks, Shire's core attention-deficit hyperactivity disorder (ADHD) franchise delivered the goods, with Vyvanse (lisdexamfetamine) and Adderall XR (mixed amphetamine salts) doing better than expected. ... Vyvanse grew 15 per cent to
More from news
Approximately 3 fully matching, plus 76 partially matching documents found.
During that time Shire has grown substantially, although has struggled in recent years with generic competition for big-selling attention deficit-hyperactivity disorder (ADHD) drug Adderall XR and plans to downsize
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....